Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 24, No 21 (July 20), 2006: pp. 3513
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.06.4329

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Provencio, M.
Right arrow Articles by España, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Provencio, M.
Right arrow Articles by España, P.
Related Articles
Right arrowRelated Reply
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

CORRESPONDENCE

Association Between Hepatitis C Virus and Non-Hodgkin's Lymphomas

Mariano Provencio, Antonio Sánchez, Félix Bonilla, Pilar España

Hospital Clínica Puerta de Hierro, Madrid, Spain

To the Editor:

In the February 20, 2006, issue of the Journal of Clinical Oncology, Besson et al1 reported that the Groupe d'Etude des Lymphomes de l'Adulte found differences in clinical presentation and worsened prognosis in 26 patients with diffuse large-cell lymphoma (DLCL) and hepatitis C virus infection (HCV) compared with DLCL HCV-negative patients. Only patients who were included in the clinical trial were studied and the prevalence in the population selected was 0.5%. Our group examined 114 patients with non-Hodgkin's lymphoma who were not selected, except for the exclusion of patients who were seropositive against the AIDS virus and parenteral drug addicts. We detected 15 HCV positives (13%). We did not find significant differences in relation to the presence or absence of HCV infection in the clinical presentation, nor did we find any association between high- or low-malignancy grade. We did find a significant difference in global survival between the eight DLCL patients who were HCV positive (75% at 2 years; 95% CI, 45% to 100%) and the 50 DLCL patients who were HCV negative (94% at 2 years; 95% CI, 87% to 100%; P = .022). We found no relation between HCV infection and survival in the rest of the patients grouped as low-grade lymphomas. In our experience the percentage of HCV infection is similar in high- and low-grade lymphomas, and prognosis is no worse in the latter. We found a greater prevalence of HCV infection and lymphomas than that reported for the selected population studied by Groupe d'Etude des Lymphomes de l'Adulte.

Authors' Disclosures of Potential Conflicts of Interest
The authors indicated no potential conflicts of interest.

REFERENCES

1. Besson C, Canioni D, Lepage E, et al: Characteristicis and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Ádulte Programs. J Clin Oncol 24:953-960, 2006[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Reply

  • In Reply
    Caroline Besson, Francois Lefrere, Felipe Suarez, Felix Reyes, and Olivier Hermine
    JCO 2006 24: 3513-3514 [Full Text]



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Provencio, M.
Right arrow Articles by España, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Provencio, M.
Right arrow Articles by España, P.
Related Articles
Right arrowRelated Reply
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online